Trial intelligence / Profile preview

Bepotastine Besilate in Seasonal Allergic Conjunctivitis

NCT01174823Phase 2Completed

Sponsor
Bausch + Lomb
Start
Jun 2010
Primary completion
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bepotastine in seasonal allergic conjunctivitis (SAC), sponsored by Bausch + Lomb. Started Jun 2010; status: completed.

02

Drugs

bepotastine
03

Conditions

seasonal allergic conjunctivitis (SAC)

Beyond the preview

Go deeper on NCT01174823.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01174823.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call